Our analysis demonstrated that COPD patients with COVID-19 had a higher risk for healthcare utilization, although adjusted in-hospital mortality risk was not different than the non-COPD patients with COVID-19.
Primary prophylactic administration of G-CSF and loperamide resulted in a clinically relevant reduction of the incidence and severity of sacituzumab govitecan-related neutropenia and diarrhea.
Innovations introduced by this analysis include non-parametric modelling of the exposure-response relationship between RSV activity and hospitalizations and evaluating the predictive reliability of two RSV…
In patients undergoing major spinal or cytoreductive surgery for pseudomyxoma peritonei (PMP), FC was non-inferior to FFP/Cryo for the management of clinically relevant intraoperative bleeding.…
The evidence of the heterogeneity of WAS and XLT outcomes could be instrumental to draw updated recommendations for the management of the patients affected by…
This meta-analysis provides an up-to-date comprehensive global overview that cancer survivors had increased risk of CVD and 17 CVD subtypes than non-cancer controls. CVD risk…
HBM4003 combined with toripalimab demonstrated promising anti-tumor activity and manageable safety in patients with refractory NENs, supporting further investigation of this combination therapy.
Editors at eClinicalMedicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly…
Dr. Jan Hontelez and Professor Till Barnighausen join Sundus Ahmad to discuss their modelling study which predicted changes in HIV deaths and new infections due…
